These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 28607363)
1. Development of a selective agonist for relaxin family peptide receptor 3. Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363 [TBL] [Abstract][Full Text] [Related]
2. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids. Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931 [TBL] [Abstract][Full Text] [Related]
3. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4. Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393 [TBL] [Abstract][Full Text] [Related]
4. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays. Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442 [TBL] [Abstract][Full Text] [Related]
5. Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5. Wang JH; Shao XX; Hu MJ; Liu YL; Xu ZG; Guo ZY Amino Acids; 2019 Apr; 51(4):619-626. PubMed ID: 30604098 [TBL] [Abstract][Full Text] [Related]
6. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays. Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726 [TBL] [Abstract][Full Text] [Related]
7. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5. Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634 [TBL] [Abstract][Full Text] [Related]
8. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7. Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155 [TBL] [Abstract][Full Text] [Related]
9. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation. Hu MJ; Shao XX; Li HZ; Nie WH; Wang JH; Liu YL; Xu ZG; Guo ZY Amino Acids; 2018 Aug; 50(8):1111-1119. PubMed ID: 29770870 [TBL] [Abstract][Full Text] [Related]
10. Rapid preparation of bioluminescent tracers for relaxin family peptides using sortase-catalysed ligation. Wang JH; Shao XX; Hu MJ; Wei D; Nie WH; Liu YL; Xu ZG; Guo ZY Amino Acids; 2017 Sep; 49(9):1611-1617. PubMed ID: 28631012 [TBL] [Abstract][Full Text] [Related]
11. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation. Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387 [TBL] [Abstract][Full Text] [Related]
12. Exploring electrostatic interactions of relaxin family peptide receptor 3 and 4 with ligands using a NanoBiT-based binding assay. Wang JH; Nie WH; Shao XX; Li HZ; Hu MJ; Liu YL; Xu ZG; Guo ZY Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):776-786. PubMed ID: 30684458 [TBL] [Abstract][Full Text] [Related]
13. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135). Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868 [TBL] [Abstract][Full Text] [Related]
14. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization. Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621 [TBL] [Abstract][Full Text] [Related]
15. Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus. Ganella DE; Callander GE; Ma S; Bye CR; Gundlach AL; Bathgate RA Gene Ther; 2013 Jul; 20(7):703-16. PubMed ID: 23135160 [TBL] [Abstract][Full Text] [Related]
16. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology. Kristensson L; Mayer G; Ploj K; Wetterlund M; Arlbrandt S; Björquist A; Wissing BM; Castaldo M; Larsson N Eur J Pharmacol; 2015 Jan; 747():123-31. PubMed ID: 25496752 [TBL] [Abstract][Full Text] [Related]
17. Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay. Li HZ; Li N; Shao XX; Liu YL; Xu ZG; Guo ZY Biochimie; 2020 Oct; 177():117-126. PubMed ID: 32810565 [TBL] [Abstract][Full Text] [Related]
18. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3). Kocan M; Sarwar M; Hossain MA; Wade JD; Summers RJ Br J Pharmacol; 2014 Jun; 171(11):2827-41. PubMed ID: 24641548 [TBL] [Abstract][Full Text] [Related]
19. Engineering of chimeric peptides as antagonists for the G protein-coupled receptor, RXFP4. Praveen P; Bathgate RAD; Hossain MA Sci Rep; 2019 Nov; 9(1):17828. PubMed ID: 31780677 [TBL] [Abstract][Full Text] [Related]
20. Relaxin-3, INSL5, and their receptors. Liu C; Lovenberg TW Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]